| Q99402679 | A Case of Celiac Disease Complicated by Rhabdomyolysis |
| Q88956194 | A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies |
| Q33395385 | A catalogue of Triticum monococcum genes encoding toxic and immunogenic peptides for celiac disease patients |
| Q44398318 | A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens |
| Q43004901 | A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin |
| Q34655666 | A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. |
| Q24683342 | A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity |
| Q33312515 | A tertiary twist to the transglutaminase tale |
| Q40966549 | Absorption and presentation of antigens by epithelial cells of the small intestine: hypotheses and predictions relating to the pathogenesis of coeliac disease |
| Q21563352 | Accurate and robust genomic prediction of celiac disease using statistical learning |
| Q37818449 | Adaptive T-cell responses regulating oral tolerance to protein antigen |
| Q42923629 | Ages of celiac disease: from changing environment to improved diagnostics |
| Q33661205 | Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients |
| Q56891624 | An Overview of Celiac Disease in Childhood Type 1 Diabetes |
| Q34410642 | Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease |
| Q24680221 | Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease |
| Q22305469 | Antigen Presentation to Celiac Lesion-Derived T Cells of a 33-Mer Gliadin Peptide Naturally Formed by Gastrointestinal Digestion |
| Q40222230 | Association of PTPN22 Single Nucleotide Polymorphisms with Celiac Disease |
| Q41064237 | Binding of gluten-derived peptides to the HLA-DQ2 (alpha1*0501, beta1*0201) molecule, assessed in a cellular assay |
| Q56907542 | Blockage of T-cell costimulation inhibits T-cell action in celiac disease |
| Q56907069 | CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study |
| Q39042122 | CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes |
| Q74036191 | CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine |
| Q36966610 | CD62L(neg)CD38⁺ expression on circulating CD4⁺ T cells identifies mucosally differentiated cells in protein fed mice and in human celiac disease patients and controls |
| Q35864046 | Celiac Disease Histopathology Recapitulates Hedgehog Downregulation, Consistent with Wound Healing Processes Activation |
| Q52885613 | Celiac Disease. |
| Q59813523 | Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies |
| Q78564328 | Celiac disease |
| Q56638533 | Celiac disease |
| Q22306535 | Celiac disease and non-celiac gluten sensitivity |
| Q34097944 | Celiac disease--a worldwide problem |
| Q43949169 | Celiac disease: a reappraisal |
| Q38669146 | Celiac disease: from etiological factors to evolving diagnostic approaches |
| Q34903220 | Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. |
| Q34128112 | Celiac disease: how complicated can it get? |
| Q34848590 | Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients |
| Q34266102 | Characterization of cereal toxicity for celiac disease patients based on protein homology in grains |
| Q37285295 | Children with celiac disease and high tTGA are genetically and phenotypically different |
| Q73700330 | Classification of cytotoxic T-cell and natural killer cell lymphomas |
| Q37072631 | Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives |
| Q98177686 | Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder |
| Q78452801 | Coeliac disease |
| Q88643735 | Coeliac disease |
| Q95389546 | Coeliac disease |
| Q73437784 | Coeliac disease |
| Q38408084 | Coeliac disease - from genetic and immunological studies to clinical applications. |
| Q28263872 | Coeliac disease and gluten-related disorders in childhood |
| Q36203298 | Coeliac disease and risk of tuberculosis: a population based cohort study. |
| Q34624665 | Coeliac disease--all questions answered? |
| Q34571582 | Coeliac disease: an update for pathologists |
| Q34810240 | Coeliac disease: dissecting a complex inflammatory disorder |
| Q81614099 | Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease |
| Q24670764 | Cytokine profiles of cultured microvascular endothelial cells from the human intestine |
| Q41056162 | Cytokines and gastrointestinal disease mechanisms |
| Q47098929 | Deep sequencing of blood and gut T-cell receptor β-chains reveals gluten-induced immune signatures in celiac disease |
| Q80199811 | Deficiency of 6B11+ invariant NK T-cells in celiac disease |
| Q35953847 | Deficiency of invariant natural killer T cells in coeliac disease |
| Q91975733 | Detection and Quantitation of Gluten in Fermented-Hydrolyzed Foods by Antibody-Based Methods: Challenges, Progress, and a Potential Path Forward |
| Q53432676 | Development of gliadin-specific immune responses in children with HLA-associated genetic risk for celiac disease. |
| Q33956436 | Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology |
| Q37088595 | Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease |
| Q33498360 | Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation |
| Q34978613 | Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires |
| Q38334300 | Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production |
| Q39400903 | Direct cloning and tetramer staining to measure the frequency of intestinal gluten-reactive T cells in celiac disease |
| Q88660930 | Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease |
| Q88538287 | Diverse developmental pathways of intestinal intraepithelial lymphocytes |
| Q41353475 | Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells |
| Q33338506 | Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms |
| Q40935592 | Evidence for cell-mediated hypersensitivity as an important pathogenetic mechanism in food intolerance |
| Q35032028 | Exome sequencing of 75 individuals from multiply affected coeliac families and large scale resequencing follow up. |
| Q42594413 | Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy |
| Q73149123 | Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy |
| Q74451664 | Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease |
| Q34691441 | Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil |
| Q36304110 | Future therapeutic options for celiac disease |
| Q38012460 | Future treatment strategies for celiac disease. |
| Q34379730 | Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation |
| Q54617426 | Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. |
| Q34795392 | Genetic difference in HLA-DR phenotypes between coeliac disease and transitory gluten intolerance |
| Q33861799 | Genetic differences in HLA-DQA1* and DQB1* allelic distributions between celiac and control children in Santiago, Chile |
| Q56903217 | Genomewide search and association studies in a Finnish celiac disease population: Identification of a novel locus and replication of the HLA and CTLA4 loci |
| Q42011657 | Getting to grips with gluten |
| Q31091532 | Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process |
| Q35869122 | Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis |
| Q43003822 | Gliadin peptide specific intestinal T cells in coeliac disease |
| Q48364966 | Gliadin-reactive T cells in Italian children from preventCD cohort at high risk of celiac disease. |
| Q77164863 | Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease |
| Q34409086 | Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma |
| Q37067094 | Gluten-sensitive enteropathy coincides with decreased capability of intestinal T cells to secrete IL-17 and IL-22 in a macaque model for celiac disease |
| Q40978106 | Gluten-sensitive enteropathy. |
| Q36224141 | Gluten: a two-edged sword. Immunopathogenesis of celiac disease |
| Q78415749 | Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders |
| Q81114338 | HLA and disease |
| Q40933856 | HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope |
| Q38354529 | HLA class II region genes and susceptibility to dermatitis herpetiformis: DPB1 and TAP2 associations are secondary to those of the DQ subregion |
| Q28209245 | HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried |
| Q30279299 | HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study |
| Q33998193 | HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease |
| Q47185351 | HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome |
| Q36351049 | HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing |
| Q38792554 | Healthy HLA-DQ2.5+ Subjects Lack Regulatory and Memory T Cells Specific for Immunodominant Gluten Epitopes of Celiac Disease. |
| Q39747742 | Heritability of non-HLA genetics in coeliac disease: a population-based study in 107 000 twins |
| Q52925804 | High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires. |
| Q33285135 | Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease |
| Q34408127 | Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody |
| Q34034818 | Histopathology of celiac disease |
| Q30309445 | Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation |
| Q90440122 | IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine |
| Q38138107 | IL-17 producing T cells in celiac disease: angels or devils? |
| Q73783346 | Identical T-cell receptor beta chain rearrangements are present in T cells infiltrating the jejunal mucosa of untreated celiac patients |
| Q28243044 | Identification of tissue transglutaminase as the autoantigen of celiac disease |
| Q24646948 | Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies |
| Q38824682 | Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease. |
| Q39493233 | Immunogenetics of non celiac gluten sensitivity |
| Q55041860 | Immunohistochemical analysis of coeliac mucosa following ingestion of oats. |
| Q81980710 | Immunopathogenesis of celiac disease |
| Q42362099 | Immunopathology of childhood celiac disease-Key role of intestinal epithelial cells |
| Q41465547 | Immunopathology of gluten-sensitive enteropathy |
| Q40966585 | Impaired binding of a DQ2 and DQ8-binding HSV VP16 peptide to a DQA1*0501/DQB1*0302 trans class II heterodimer |
| Q64891552 | In vitro differentiation of human monocytes into dendritic cells by peptic-tryptic digest of gliadin is independent of genetic predisposition and the presence of celiac disease. |
| Q45280617 | In vitro gliadin challenge: diagnostic accuracy and utility for the difficult diagnosis of celiac disease |
| Q37979161 | In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options |
| Q43868651 | In vitro presentation of gliadin-derived peptides by different cell lines |
| Q77749136 | Increased HLA-DQ2-affinity of a synthetic gliadin peptide by acid-induced deamidation of glutamine residues |
| Q35565543 | Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease |
| Q50959674 | Increased peripheral blood CD4+ T cell responses to deamidated but not to native gliadin in children with coeliac disease. |
| Q36209729 | Innate and adaptive immunity: the yin and yang of celiac disease |
| Q72714113 | Interleukin-2 and interferon-gamma producing cells in the lamina propria in celiac disease |
| Q40328831 | Intestinal T cell responses to cereal proteins in celiac disease |
| Q35835769 | Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease |
| Q34551370 | Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria |
| Q73480234 | Intestinal alphabeta T cells of symptomatic celiac disease patients show oligoclonal TCRBV repertoire but polyclonal rearrangement patterns |
| Q41451348 | Invited anniversary review: HLA associated diseases |
| Q38346187 | Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? |
| Q34370394 | Is gluten a cause of gastrointestinal symptoms in people without celiac disease? |
| Q51059143 | Isolation and characterization of circulating tissue transglutaminase-specific T cells in coeliac disease. |
| Q35364469 | Keratinocyte growth factor and coeliac disease. |
| Q38072065 | Latest in vitro and in vivo models of celiac disease |
| Q35540224 | Liver complications in celiac disease |
| Q73664138 | Local challenge of oral mucosa with gliadin in patients with coeliac disease |
| Q37706290 | Looking for celiac disease in Italian women with endometriosis: a case control study |
| Q36430136 | MHC class II proteins and disease: a structural perspective |
| Q46435012 | Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease-associated HLA-DQ2 molecule. |
| Q74330967 | Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4 |
| Q36585030 | Mechanisms of disease: immunopathogenesis of celiac disease |
| Q84586230 | Mechanisms of gastrointestinal reactions to food |
| Q42244333 | Molecular biology of coeliac disease |
| Q31038697 | Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides |
| Q38089745 | Molecular diagnosis of celiac disease: are we there yet? |
| Q77620774 | New tool to predict celiac disease on its way to the clinics |
| Q35951955 | Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. |
| Q36209713 | Non-classical MHC class I molecules on intestinal epithelial cells: mediators of mucosal crosstalk |
| Q38958324 | On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy). |
| Q50026308 | Outcome measures in coeliac disease trials: the Tampere recommendations. |
| Q53561782 | Parental knowledge of coeliac disease. |
| Q34538217 | Pathogenesis of coeliac disease: implications for treatment |
| Q79254581 | Pathomechanisms in Celiac Disease |
| Q34307239 | Pathophysiology of celiac disease |
| Q51595142 | Peptide Binding Prediction to Five Most Frequent HLA-DQ Proteins - a Proteochemometric Approach. |
| Q34392038 | Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule |
| Q52050036 | Peripheral blood in Sjögren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinant Ro/SS-A 52 kD and La/SS-B 48 kD autoantigens. |
| Q36539486 | Possible drug targets for celiac disease |
| Q40785550 | Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease |
| Q71693082 | Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease |
| Q43226379 | Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation |
| Q34379763 | Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry |
| Q91650661 | Recent Progress and Recommendations on Celiac Disease From the Working Group on Prolamin Analysis and Toxicity |
| Q22306523 | Recent advances in coeliac disease |
| Q33764385 | Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells |
| Q71565752 | Role of T cell receptor delta gene in susceptibility to celiac disease |
| Q90031404 | Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease |
| Q44970541 | Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity |
| Q37119557 | Shared and unique common genetic determinants between pediatric and adult celiac disease. |
| Q91287013 | Single-cell TCR sequencing of gut intraepithelial γδ T cells reveals a vast and diverse repertoire in celiac disease |
| Q36284180 | Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin |
| Q24674073 | Specificity of tissue transglutaminase explains cereal toxicity in celiac disease |
| Q24633885 | Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease |
| Q39217707 | T Cells in Celiac Disease. |
| Q59632319 | T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC) |
| Q41464665 | T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules |
| Q35597668 | T cells in peripheral blood after gluten challenge in coeliac disease |
| Q41478611 | T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1∗0501, β1∗0201) heterodimer |
| Q34118456 | T-cell reactivity to beta-cell antigens in human insulin-dependent (type 1) diabetes mellitus. Implications for diagnosis and therapy |
| Q38021639 | Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes |
| Q42108663 | Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. |
| Q41184071 | The HLA associated predisposition to type 1 diabetes and other autoimmune diseases |
| Q24601971 | The Oslo definitions for coeliac disease and related terms |
| Q38005620 | The adaptive immune response in celiac disease. |
| Q38934797 | The distribution of DQ genes in the Saharawi population provides only a partial explanation for the high celiac disease prevalence. |
| Q46758935 | The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease |
| Q34715395 | The genetics of autoimmune polyendocrine syndrome type II. |
| Q34423420 | The immune recognition of gluten in coeliac disease |
| Q24671041 | The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase |
| Q36432216 | The likelihood ratio and frequency of DQ2/DQ8 haplotypes in Iranian patients with celiac disease |
| Q35549432 | The molecular basis of celiac disease |
| Q47918307 | The molecular diversity of α-gliadin genes in the tribe Triticeae |
| Q34273611 | The pathogenesis of coeliac disease |
| Q33761129 | The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes |
| Q58774107 | The puzzling relationship between human leukocyte antigen HLA genes and celiac disease |
| Q42718120 | The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease |
| Q35683308 | The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease |
| Q39427548 | The roles of MHC class II genes and post-translational modification in celiac disease |
| Q28249095 | Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms |
| Q47982815 | Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease |
| Q37638199 | Tissue-mediated control of immunopathology in coeliac disease |
| Q92188877 | To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease |
| Q37247193 | Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. |
| Q42044015 | Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes |
| Q37283086 | Triggers and drivers of autoimmunity: lessons from coeliac disease |
| Q36345782 | Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet |
| Q27028121 | Vaccine against autoimmune disease: antigen-specific immunotherapy |
| Q72671648 | Wheat peptide challenge in coeliac disease |